Feasibility of idiotype vaccination in relapsed B-cell malignancies.
Inogés
Susana
S
Rodríguez-Calvillo
Mercedes
M
López-Díaz de Cerio
Ascensión
A
Zabalegui
Natalia
N
Pérez-Calvo
Javier
J
Panizo
Carlos
C
Hernandez
Milagros
M
Cuesta
Braulia
B
Rocha
Eduardo
E
Bendandi
Maurizio
M
D019496:Cancer Vaccines / Q000096:biosynthesis / Q000276:immunology / Q000627:therapeutic use*; D017326:Clinical Trials, Phase III as Topic; D003131:Combined Modality Therapy; D005240:Feasibility Studies; D006801:Humans; D006825:Hybridomas / Q000276:immunology; D007130:Immunoglobulin Idiotypes / Q000276:immunology*; D015448:Leukemia, B-Cell / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D016393:Lymphoma, B-Cell / Q000188:drug therapy / Q000276:immunology / Q000628:therapy*; D014611:Vaccination
D019496:Cancer Vaccines; D007130:Immunoglobulin Idiotypes